Bruker (NASDAQ:BRKR) executives used a conference presentation and Q&A session to outline what they described as an ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.